Effect of eplerenone on markers of bone turnover in patients with primary hyperparathyroidism - The randomized, placebo-controlled EPATH trial

Verheyen, N; Grubler, MR; Meinitzer, A; Trummer, C; Schwetz, V; Amrein, K; Dimai, HP; Marz, W; Catena, C; von Lewinski, D; Voelkl, J; Alesutan, I; Fahrleitner-Pammer, A; Brussee, H; Pilz, S; Tomaschitz, A

Verheyen, N (reprint author), Med Univ Graz, Dept Cardiol, Auenbruggerpl 15, A-8036 Graz, Austria.

BONE, 2017; 105 ( ): 212

Abstract

Mineralocorticoid receptor (MR) antagonism may affect bone turnover via direct and indirect pathways involving parathyroid hormone, but randomized con......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索